- Home
- Supplements
- Apigenin
- NAD+ Restoration
Apigenin for NAD+ Restoration
Apigenin inhibits the NAD-consuming enzyme CD38 in laboratory models, but human NAD data is absent.
Overview
Verdict
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- No human dose established
- Expected timeframe
- Not established
Protocol
- studied dose
- Mouse studies used the equivalent of high oral doses to inhibit CD38 and raise tissue NAD
- evidence note
- Verdict is insufficient - no human trial has measured NAD after apigenin
- what happened
- Tissue NAD rose and metabolic parameters improved in mice; oral bioavailability in humans is low and no human NAD measurement exists
- better first choices
- NMN or nicotinamide riboside have at least measured human NAD elevation, though clinical benefit remains unproven
- if you still trial it
- There is no dose to recommend and no accessible way to verify a change in your NAD levels
Evidence
What the studies say
No studies are yet linked to both Apigenin and NAD+ Restoration.
Safety
Caveats
Human bioavailability of oral apigenin is low, so mouse tissue concentrations are unlikely to be reached. Apigenin inhibits CYP enzymes and can raise levels of some medications. Avoid in pregnancy and alongside anticoagulants without medical advice.
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.